These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 10169671)

  • 1. Prednicarbate versus fluocortin for inflammatory dermatoses. A cost-effectiveness study.
    de Tiedra A; Mercadal J; Lozano R
    Pharmacoeconomics; 1997 Aug; 12(2 Pt 1):193-208. PubMed ID: 10169671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double-blind study of prednicarbate versus fluocortin butyl ester in atopic dermatitis.
    Aliaga A; Rodríguez M; Armijo M; Bravo J; Avila AL; Mascaro JM; Ferrando J; Del Rio R; Lozano R; Balaguer A
    Int J Dermatol; 1996 Feb; 35(2):131-2. PubMed ID: 8850046
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical trial of fluocortin butylester in a double-blind contralateral comparison versus fluocortolone and hydrocortisone acetate (author's transl)].
    Reckers R
    Arzneimittelforschung; 1977; 27(11a):2240-4. PubMed ID: 341901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prednicarbate activity and benefit/risk ratio in relation to other topical glucocorticoids.
    Schäfer-Korting M; Korting HC; Kerscher MJ; Lenhard S
    Clin Pharmacol Ther; 1993 Oct; 54(4):448-56. PubMed ID: 8222488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prednicarbate (Dermatop): profile of a corticosteroid.
    Gupta AK; Chow M
    J Cutan Med Surg; 2004; 8(4):244-7. PubMed ID: 16092003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Photographic follow-up of the topical use of prednicarbate preparations in inflammatory dermatoses].
    Schulz H
    Z Hautkr; 1986; 61 Suppl 1():51-61. PubMed ID: 3705673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Topical use of prednicarbate preparations in children].
    Schulz H; Maue R; Meyer-Latzke E
    Z Hautkr; 1986; 61 Suppl 1():41-50. PubMed ID: 2939635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modern topical glucocorticoids and anti-infectives for superinfected atopic eczema: do prednicarbate and didecyldimethylammoniumchloride form a rational combination?
    Korting HC; Zienicke H; Braun-Falco O; Bork K; Milbradt R; Nolting S; Schöpf E; Tronnier H
    Infection; 1994; 22(6):390-4. PubMed ID: 7698835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of acute episodes of atopic dermatitis. Double-blind comparative study with 0.05% halometasone cream versus 0.25% prednicarbate cream].
    Ulrich R; Andresen I
    Fortschr Med; 1991 Dec; 109(36):741-4. PubMed ID: 1778534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review of prednicarbate (Dermatop).
    Gupta AK; Chow M
    Skin Therapy Lett; 2004 Dec-2005 Jan; 9(10):5-6, 9. PubMed ID: 15657633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-utility analysis of intravenous immunoglobulin and prednisolone for chronic inflammatory demyelinating polyradiculoneuropathy.
    McCrone P; Chisholm D; Knapp M; Hughes R; Comi G; Dalakas MC; Illa I; Kilindireas C; Nobile-Orazio E; Swan A; Van den Bergh P; Willison HJ;
    Eur J Neurol; 2003 Nov; 10(6):687-94. PubMed ID: 14641514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prednicarbate emollient cream 0.1% in pediatric patients with atopic dermatitis.
    Moshang T
    Cutis; 2001 Jul; 68(1):63-9. PubMed ID: 11480151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness analysis of tacrolimus ointment versus high-potency topical corticosteroids in adults with moderate to severe atopic dermatitis.
    Ellis CN; Drake LA; Prendergast MM; Abramovits W; Boguniewicz M; Daniel CR; Lebwohl M; Paller AS; Stevens SR; Whitaker-Worth DL; Tong KB
    J Am Acad Dermatol; 2003 Apr; 48(4):553-63. PubMed ID: 12664019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of fluocortin butylester (0.75%) as an ointment in the pyrexal erythema test on human skin (author's transl)].
    Heite HJ; Etspüler J
    Arzneimittelforschung; 1977; 27(11a):2234-5. PubMed ID: 580035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prednicarbate: a review of its pharmacological properties and therapeutic use in the treatment of dermatological disorders.
    Spencer CM; Wagstaff AJ
    BioDrugs; 1998 Jan; 9(1):61-86. PubMed ID: 18020557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prednicarbate--the epidermis-corticoid among the topical corticoids].
    Hautarzt; 1998 Apr; 49(4 Suppl):1-16. PubMed ID: 9595306
    [No Abstract]   [Full Text] [Related]  

  • 18. [Galenic and clinico-pharmacologic studies of prednicarbate (Hoe 777)].
    Petri W; Frosch PJ; Savopoulos C; Rupp W; Sittig W
    Z Hautkr; 1986; 61 Suppl 1():62-73. PubMed ID: 3705674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Fluocortin butyl in various dermatoses in childhood].
    Nemelka O; Occella C; Schiazza L; Persi A; Rampini E
    G Ital Dermatol Venereol; 1983; 118(1):VII-X. PubMed ID: 6358002
    [No Abstract]   [Full Text] [Related]  

  • 20. Prednicarbate (dermatop): a review.
    Gupta AK; Chow M
    J Drugs Dermatol; 2004; 3(5):553-6. PubMed ID: 15552608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.